Physician

Gina Pietras Spohn, MD

According to 2025 Medicare claims, Gina Spohn, MD (NPI: 1952729774) practices dermatology in the Green Bay, WI market, with the plurality of this provider's patient population coming from Brown, WI. This provider's primary affiliated billing organization is FOREFRONT DERMATOLOGY, S.C. (NPI: 1760437644; TIN: 391351587) and primary practice location at 54313-6717.

Spohn's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 304 traditional Medicare patients, billed 1,242 HCPCS/CPT codes, and received $66,785 in Medicare payments. The top billing code was 99203 (New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more). Part D data shows 745 prescription claims across 406 beneficiaries totaling $225,797 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 12 records totaling $278. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $30,633 and ending at $225,797. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$75K$150K2018 Medicare payment: $14,795 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $103,060 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $83,272 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $115,540 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $124,755 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $149,837 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $66,785 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
201877292$14,795
20193852,115$103,060
20203891,916$83,272
20214102,323$115,540
20225362,946$124,755
20236363,468$149,837
20243041,242$66,785

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$148K$296K2015 Drug cost: $30,633 (USD; Tot_Drug_Cst)2016 Drug cost: $89,285 (USD; Tot_Drug_Cst)2017 Drug cost: $262,337 (USD; Tot_Drug_Cst)2018 Drug cost: $127,853 (USD; Tot_Drug_Cst)2019 Drug cost: $27,822 (USD; Tot_Drug_Cst)2020 Drug cost: $30,082 (USD; Tot_Drug_Cst)2021 Drug cost: $42,680 (USD; Tot_Drug_Cst)2022 Drug cost: $209,327 (USD; Tot_Drug_Cst)2023 Drug cost: $296,329 (USD; Tot_Drug_Cst)2024 Drug cost: $225,797 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201561153$30,633
201669243$89,285
201796349$262,337
2018131338$127,853
2019311664$27,822
2020344776$30,082
2021419959$42,680
20225071,252$209,327
20236481,490$296,329
2024406745$225,797

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99203New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more7474$76
11102Biopsy of related skin growth, first growth8591$67
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more164189$65
17000Destruction of precancer skin growth, 1 growth91106$38
17003Destruction of precancer skin growth, 2-14 growths68330$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab16504$66,924
Clobetasol PropionateClobetasol Propionate922,413$3,272
KetoconazoleKetoconazole1945,367$2,686
TacrolimusTacrolimus14385$2,010
MetronidazoleMetronidazole22596$1,058

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.12$278Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Gina Pietras Spohn, MD?

Tedicare shows public-source Medicare data for Gina Pietras Spohn, MD (NPI 1952729774), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Gina Pietras Spohn, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Gina Pietras Spohn, MD?

Gina Pietras Spohn, MD is linked to FOREFRONT DERMATOLOGY, S.C. (billing NPI 1760437644) in the available physician profile data.

Does Gina Pietras Spohn, MD have Open Payments data?

Gina Pietras Spohn, MD has 12 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.